U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300631) titled 'SpaceOAR Post-Market Registry Study' on Nov. 19.
Brief Summary: Recently, concerns have been raised by regulators that there is little data about the long-term safety of rectal hydrogel spacers for use in conjunction with radiotherapy treatment for prostate cancer. To address this, this study will collect data about the short-term side-effects and long-term safety of SpaceOAR and SpaceOAR Vue rectal hydrogel spacers in men who receive them in the UK and France. Men who have agreed to receive these spacers as part of their standard medical care will be asked to take part in the study whereby data about their treatment and health will...